MBP metabolic pharmaceuticals limited

Just spoke to MBP suggesting their quarterly report was kind of...

  1. 1,140 Posts.
    lightbulb Created with Sketch. 94
    Just spoke to MBP suggesting their quarterly report was kind of overdue.

    They advised they have opted to hold fire until they release the results of the ACV1 Neuropathic Pain Phase 2 study.

    And, as the study is over and results are being compiled keep an eye on the price to give an indication of which way the insiders are calling it!

    Did I say that, shame on me ASIC. Losers!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.